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Among the amino acids with the fastest in vitro spontaneous racemization rates, the D-
stereoisomer of aspartic acid and serine are found endogenously in mammalian systems.  
However, the D-stereoisomer of the amino acid with the fastest in vitro spontaneous 
racemization rate, cysteine, has never been examined.  We use high-performance liquid 
chromatography utilizing a chiral crown ether column as a chiral selector to establish the 
presence of endogenous mammalian D-cysteine.  Based on the fact that D-cysteine is used 
in the chemical synthesis of D-luciferin, the substrate for firefly luciferase, from 2-cyano-
6-hydroxybenzothiazole, a luciferase bioluminescence assay for the stereo-specific 
detection of D-cysteine is used.  The assay readily detects 0.1-1.0 µM D-cysteine and so is 
suitable for monitoring physiologic mammalian tissue levels of D-cysteine.  Based on this 
assay we develop a method for the in vivo optical imaging of endogenous D-cysteine in 
transgenic mice overexpressing firefly luciferase.  Using this method, we find relatively 
high levels of D-cysteine in the eyes and a transverse thoraco-abdominal organ, which on 
dissection is identified as the pancreas.  We identify serine racemase and D-amino acid 
oxidase as candidate enzymes for the endogenous biosynthesis and degradation of 
mammalian D-cysteine, respectively.  We find that serine racemase knockout mice 
develop an age-related impairment in vision.  Electroretinogram responses are attenuated 
in older serine racemase knockout mice compared to age-matched wildtype controls.  
Both scotopic a-waves and b-waves are severely attenuated, photopic b-waves are also 
diminished.  Electroretinogram responses are unaffected in D-amino acid oxidase 
knockout mice compared to age-matched wildtype controls.  Retinal fundus photography 
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indicates focal disruptions of the retinal pigmented epithelium in older serine racemase 
knockout mice.  In toluidine blue-stained retinal sections, overall thinning of the retina is 
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Chapter 1.  Discovery of mammalian D-cysteine. 
 
Summary:  The presence of endogenous mammalian D-cysteine is established by high-
performance liquid chromatography utilizing a chiral crown ether column as a chiral 
selector.  A method for the in vivo optical imaging of endogenous D-cysteine in 
transgenic mice overexpressing firefly luciferase is developed.  It is based on the fact that 
D-cysteine is used in the chemical synthesis of D-luciferin, the substrate for firefly 
luciferase, from 2-cyano-6-hydroxybenzothiazole.  In vivo optical imaging of endogenous 
D-cysteine in transgenic mice overexpressing firefly luciferase indicate relatively high 
levels of D-cysteine in the eyes and a transverse thoraco-abdominal organ, which on 
dissection is identified as the pancreas.  Candidate enzymes for the endogenous 
biosynthesis and degradation of mammalian D-cysteine are serine racemase and D-amino 
acid oxidase, respectively.  Serine racemase knockout mice develop an age-related vision 
impairment which we characterize. 
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Chapter 1a.  Introduction 
 
Molecular Chirality 
In 1848, Louis Pasteur first described molecular chirality studying crystals of tartrates 
(Pasteur, 1848a; Pasteur, 1848b; Kauffman & Myers, 1998; Gal, 2011).  He explained 
why the newly available chemically synthesized tartrates do not rotate plane polarized 
light, i.e., are optically inactive, unlike naturally occurring tartrates, purified from living 
matter, which rotate plane polarized light, i.e., are optically active, despite otherwise 
identical physical properties, chemical properties, and elemental composition.  He 
noticed that crystals of optical active naturally occurring tartrates, are hemihedral, i.e., 
has small facets at alternate corners, with right-handed facets.  On the other hand, crystals 
of optically inactive chemically synthesized tartrates are not hemihedral, except for the 
sodium ammonium salt which has crystals that are not only hemihedral, but also 
enantiomorphic, i.e., some of the crystals has right-handed hemihedral facets, similar to 
naturally occurring tartrates, and other crystals has non-superimposable mirror image 
left-handed hemihedral facets.  He manually separated the enantiomorphic crystal forms 
and found that solutions made from crystals with right-handed hemihedral facets are 
dextrorotatory, i.e., rotate plane polarized light clockwise to the right, while solutions 
made from crystals with left-handed hemihedral facets are levorotatory, i.e., rotate plane 
polarized light anticlockwise to the left.  Solutions prepared from an equal mixture of the 
enantiomorphic crystal forms are optically inactive, i.e., do not rotate plane polarized 
light.  With this, Pasteur was the first to demonstrate molecular chirality and also the first 
to separate the two enantiomer forms of a chiral substance.  Furthermore, since naturally 
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occurring tartrates, purified from living matter, are enantiopure dextrorotatory, i.e., 
homochiral, this would be the first demonstration of homochirality in biological systems, 
something not completely appreciated at the time. 
 
Biological Homochirality 
Biological systems are homochiral, i.e., chiral molecules in biological systems 
predominantly exist as one form of the chiral enantiomers, for example, left-handed L-
amino acids and right-handed D-sugars.  Although the two enantiomeric forms of a chiral 
molecule have identical chemical and physical properties, apart from rotation of plane 
polarized light, the way it interacts with other chiral molecules is different, just as a right 
hand interacts differently with right as opposed to left hand gloves.  As a result, 
biological homochirality is critical for molecular biological processes such as molecular 
recognition in substrate-enzyme and ligand-receptor binding as well as template driven 
processes such as DNA replication, RNA transcription, and protein translation.  The 
origin of biological homochirality remains a matter of active study (Blackmond, 2010). 
 Chirality of amino acids was described by Pasteur.  In 1852, he showed that 
aspartic acid chemically synthesized by heating ammonium fumarate is optically inactive, 
while aspartic acid purified from vetch plants is optically active (Pasteur, 1852).  Proteins 
present in living organism are made exclusively from L-amino acids.  This stems from the 
stereospecificity of the biological protein synthetic machinery (Yamane et al., 1981). 
 In addition to being the basic building blocks of peptides and proteins, amino 
acids are also important metabolic precursors and intermediates in the biosynthesis of 
many important biological molecules such as serotonin, catecholamines, and nitric oxide, 
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whose amino acid precursors are L-tryptophan, L-tyrosine, and L-arginine, respectively.  
Furthermore, they could also function directly as biochemical messenger and signaling 
molecules.  This includes classical amino acid neurotransmitters, such as L-glutamate and 
glycine; and amino acid signaling (L-leucine) in autophagy (Efeyan et al., 2015).   
 Since L-amino acids are the predominant naturally occurring amino acids in 
biological systems both in proteins and as metabolic precursors and intermediates in the 
biosynthesis of a variety of important biological molecules, for a long time it was thought 
unlikely that D-amino acids were of biological significance.  Although as early as 1935, 
Hans Krebs identified an enzyme, D-amino acid oxidase, in the liver and kidneys that 
oxidatively deaminates D-amino acids and not L-amino acids (Krebs, 1935).  However, 
he was unsure of its physiological function. 
 
Discovery of biological D-amino acids 
Advancements in analytical methods for the enantiomeric separation of amino acids 
facilitate the discovery of D-amino acids in biological systems.  Peptidoglycans in 
bacterial cell walls are found to contain D-amino acids, such as D-glutamate and D-
alanine (Reaveley & Burge, 1972).  D-amino acids are also found in insects, higher 
plants, and marine invertebrates (Corrigan, 1969; Robinson, 1976; D’Aniello & Giuditta, 
1978; Felbeck, 1985; Felbeck & Wiley, 1987).  D-amino acids in mammals are first 
identified in proteins that do not undergo turnover in human tooth enamel, tooth dentine, 
and eye lens (Helfman & Bada, 1975; Helfman & Bada, 1976; Bada, 1984).  Since 
humans are long-lived mammals over time proteins that do not undergo turnover 
5 
accumulate D-amino acid residues by in situ racemization of L-amino acid residues in 
such proteins. 
 
Mammalian D-aspartic acid 
The first free D-amino acid to be identified in mammalian systems is D-aspartic acid 
(Dunlop et al., 1986).  They find the highest concentration of free D-aspartic acid in the 
cerebral hemispheres of new born rats.  In adults, they find the highest concentration of 
free D-aspartic acid in the pituitary gland.  They also observe rapidly diminishing 
postnatal levels of free D-aspartic acid with age, indicating that it is likely to play a rôle in 
development.  D-aspartic acid is a poor substrate of D-amino acid oxidase (Bender & 
Krebs, 1950).  It is degraded by the peroxisomal enzyme D-aspartate oxidase.  Using 
FAD as a cofactor it oxidizes D-aspartate to oxaloacetate, ammonia, and hydrogen 
peroxide.  D-aspartate oxidase knockout mice have markedly elevated tissue levels of D-
aspartate (Huang et al., 2006).  They have markedly increased D-aspartate 
immunoreactivity in the adrenal cortex together with basally elevated serum 
corticosterone concentration compared to wildtype mice (Weil et al., 2006).  The 
intermediate lobe of the pituitary gland, endogenously express D-aspartate oxidase and as 
a result has negligible levels of D-aspartate.  In D-aspartate oxidase knockout mice the 
pituitary intermediate lobe exhibits elevated levels of D-aspartate coupled with 
significantly reduced levels of proopiomelanocortin and α-melanocyte-stimulating 
hormone, a melanocortin.  Consistent with diminished levels of α-melanocyte-stimulating 
hormone, D-amino acid oxidase knockout mice exhibit deficits in melanocortin-
dependent behaviors, namely, increased weight gain, impaired sexual performance, and 
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decreased autogrooming (Huang et al., 2006).  In addition, D-aspartate oxidase knockout 
mice exhibit reduced immobility in the Porsolt forced swim test, and significant deficits 
in prepulse inhibition and rotarod performance (Weil et al., 2006). 
 
Mammalian D-serine 
The second free D-amino acid to be identified in mammalian systems is D-serine 
(Hashimoto et al., 1992a).  Using gas chromatography, they succeed in separating N,O-
pentafluoropropionyl isopropyl derivatives of D-serine and L-serine in rat brain extracts.  
The identity of the D-serine peak is confirmed using electron impact and positive 
chemical ionization mass spectrometry.  They estimate rat brain D-serine levels to be 
~0.27 mM, ~23% of the total serine in the brain.  They reproduce these findings using 
high-performance liquid chromatography (HPLC) in which amino acids derivatized with 
N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde are separated using HPLC 
followed by fluorimetric detection (Hashimoto et al., 1992b).  Using HPLC, rat brain D-
serine levels are determined to be ~0.22 mM, ~25% of the total serine in the brain. 
 Hashimoto et al., 1993, find that the brain distribution of D-serine resembles that 
of N-methyl-D-aspartate (NMDA) receptors.  D-serine is found to be 3-4 times more 
potent in activating the NMDA receptors than glycine itself (Matsui et al., 1995).  
Degradation of D-serine by D-amino acid oxidase markedly reduced NMDA 
neurotransmission (Mothet et al., 2000).  This supports the notion that D-serine is the 
endogenous ligand of the ‘glycine’ site of the NMDA receptor (Snyder & Kim, 2000; 
Mustafa et al., 2004).  Using an antibody against glutaraldehyde conjugated D-serine, 
immunoreactivity of D-serine is found to correlate with the distribution of NMDA 
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receptors, and inversely correlate with D-amino acid oxidase (Schell et al., 1995).  
Namely, high densities of D-serine are observed in the forebrain with extremely low 
densities in the hindbrain.  Inversely, D-amino acid oxidase is almost non-existent in the 
forebrain, with high densities in the hindbrain.  The reciprocal localization of D-amino 
acid oxidase relative to D-serine indicates that D-amino acid oxidase is the endogenous 
enzyme responsible for D-serine degradation.  Indeed, mutant mice and rats that lack D-
amino acid oxidase have markedly elevated levels of D-serine in the hindbrain which 
would otherwise have negligible D-serine levels (Yamanaka et al., 2012).  This is 
consistent with the observed high expression of D-amino acid oxidase in the hindbrain. 
The conversion of radiolabeled L-serine to D-serine was first described in the 
pupae of silkworm, Bombyx mori (Sirinivasan et al., 1965).  In mammals, conversion of 
radiolabeled L-serine to D-serine in brains of intact rats was also demonstrated (Dunlop & 
Neidle, 1997), indicating that D-serine is likely formed by the direct racemization of L-
serine by a serine racemase.  The serine racemase activity in crude pupal lysates was 
found to be too unstable to enable purification of the enzyme.  Addition of protease 
inhibitors and ammonium persulfate fractionation enabled the partial purification of a 
stably active preparation (Uo et al., 1998).  Similarly, no serine racemase activity was 
detectable in rat brain homogenates.  However, ammonium persulfate fractionation 
enabled the partial purification of a stably active preparation that enabled the purification 
(Wolosker et al., 1999a) and subsequent cloning (Wolosker et al., 1999b) of serine 
racemase. 
Binding interactions regulate serine racemase.  Glutamate receptor interacting 
protein (GRIP) physiologically binds serine racemase, activating it, enhancing D-serine 
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release (Kim et al., 2005).  Glutamate receptor activation triggers GRIP binding to serine 
racemase and its activation.  This interaction mediates the developmental migration of 
granular cells in the cerebellum, known to be enhanced by glutamate.  GRIP adenoviral 
infection of neonatal cerebellum increases granule cell migration, which is impeded by 
degradation of D-serine with D-amino acid oxidase.  Thus, in neuronal migration, 
glutamate stimulates Bergmann glia to form and release D-serine leading to activation of 
NMDA receptors on granule cells to augment migration.  Metabotropic glutamate 
receptor activation of glia also regulates serine racemase (Mustafa et al., 2009).  Receptor 
activation stimulates phospholipase C (PLC) to degrade phosphatidylinositol (4,5)-
bisphosphate (PIP2), relieving physiologic inhibition of serine racemase by PIP2.  Serine 
racemase binds protein interacting with C-kinase (PICK1) via the PDZ domain of PICK1 
(Fujii et al., 2006).  PICK1 is a susceptibility gene for schizophrenia.  D-serine levels are 
decreased in the forebrain of neonatal PICK1 knockout mice (Hikida et al., 2008).  Serine 
racemase is also regulated by binding to the scaffolding protein disrupted-in-
schizophrenia-1 (DISC1) which binds and stabilizes serine racemase (Ma et al., 2013).  
The mutant form of DISC1, associated with psychosis, fails to bind serine racemase 
leading to the degradation of serine racemase via ubiquitination, and decreases in D-
serine formation.  Transgenic mice containing mutant DISC1 exhibit behavioral 
anomalies consistent with deficient NMDA neurotransmission.  Serine racemase is 
depleted in these mice.  Thus, the abnormal behavior associated with mutant DISC1 in 
animals and patients may reflect this mechanism that leads to depletion of D-serine and 
diminished NMDA neurotransmission.  Mice with targeted deletion of serine racemase 
whose production of D-serine is profoundly decreased exhibit aberrant glutamatergic 
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neurotransmission and a variety of subtle behavioral abnormalities, reinforcing the 
importance of D-serine for physiologic NMDA transmission (Basu et al., 2008).  The rôle 
of D-serine as a pathologic as well as physiologic ligand for NMDA receptors is 
supported by findings that serine racemase deletion protects against NMDA receptor-
associated excitotoxicity in stroke (Mustafa et al., 2010). 
 Serine racemase can link α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) and NMDA neurotransmission (Ma et al., 2014).  Serine racemase binds avidly 
to stargazin, a major accessory protein for AMPA receptors.  This leads to membrane 
association of serine racemase and decreased catalytic activity.  Serine racemase also 
binds with high affinity to postsynaptic density protein 95 (PSD95) mediated by the PDZ 
ligand consensus of TVSV at its C-terminus.  The binding of serine racemase to stargazin 
provides a link to AMPA receptors.  Application of AMPA dissociates serine racemase 
from stargazin, resulting in the internalization of serine racemase and derepression of 
serine racemase activity, increasing D-serine production and potentially activating 
NMDA receptors.  These findings provide a means whereby AMPA transmission can 
influence NMDA transmission.  This interesting cross-talk between the two receptors is 
mediated by translocation of a neurotransmitter biosynthetic enzyme, a rather novel 
concept. 
Feedback by nitric oxide from post-synaptic cells also regulates serine racemase 
(Mustafa et al., 2007).  Thus, serine racemase is physiologically nitrosylated, inhibiting 
its catalytic activity.  NMDA receptor activation enhances serine racemase nitrosylation 
by stimulating neuronal nitric oxide synthase (nNOS).  By activating nNOS, NMDA 
transmission enhances serine racemase nitrosylation, supporting a model in which 
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stimulation of nitric oxide formation in NMDA-receptor containing neurons leads to 
retrograde movement of nitric oxide to presynaptic cells to decrease D-serine formation 
providing feedback inhibition of NMDA transmission.   
There had been controversy as to the localization of D-serine and its biosynthetic 
enzyme serine racemase in neurons versus glia, with the consensus emerging that there 
are localizations in both compartments (Ehmsen et al., 2013).  L-serine disposition is 
determined in major part by 3-phosphoglycerate dehydrogenase, an exclusively glial 
enzyme responsible for the committed step in the phosphorylated pathway for L-serine 
formation.  Experiments with transgenic mice expressing enhanced green fluorescent 
protein under the serine racemase promoter as well as knockout mice of serine racemase 
and/or 3-phosphoglycerate dehydrogenase establish that neuronal D-serine derives from 
glial supply of L-serine.  This forms the basis of the glia-neuron serine shuttle model 
(Wolosker & Radzishevsky, 2013).   
The Na+-independent amino acid transporter alanine-serine-cysteine transporter 1 
(Asc-1) is the primary transporter for neuronal D-serine reuptake in the mouse central 
nervous system (Rutter et al., 2007).  Asc-1 is expressed in the brain, lung, and small 
intestines.  Immunohistochemistry in rodent brains indicate widespread neuronal 
immunoreactivity (Helboe et al., 2003; Matsuo et al., 2004).  [3H]D-serine uptake in Asc-
1 knockout mice, compared to wildtype mice, is reduced to 34% in forebrain 
synaptosomes and 22% in cerebellar synaptosomes.  On omission of Na+ from the assay 
buffer, [3H]D-serine uptake in Asc-1 knockout mice, compared to wildtype mice, is 
reduced to 8% in forebrain synaptosomes and 1% in cerebellar synaptosomes.  Omission 
of Na+ from the assay buffer is necessary to halt Na+-dependent transport.  The IC50 for 
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Na+-independent D-serine uptake by Asc-1 is 19 µM.  Homozygous Asc-1 knockout mice 
develop tremors and seizures (Xie et al., 2005).  Severe seizures result in their early 
postnatal death at 36-40 days of age.  The NMDA receptor antagonist, MK-801, reduces 
both tremors and seizures in these mice.  The fatal hyperexcitability of Asc-1 knockout 




We wondered what is chemically unique about D-serine, and D-aspartic acid compared to 
other D-amino acids for them to evolve into messenger molecules in mammalian systems.  
In speculating as to why D-serine and D-aspartate but not other D-amino acids exist in 
mammalian systems, we presumed that, thermodynamically speaking, they might be 
more prone to spontaneous racemization and, in the course of evolution, racemase 
enzymes developed to carry out the process physiologically.  We started by looking up 
the in vitro spontaneous racemization rates of different amino acids (Man & Bada, 1987) 
[Table 1].  Interestingly, the in vitro spontaneous racemization half-lives of amino acids 
vary greatly [Table 1].  Among the amino acids with the fastest spontaneous racemization 
rates are serine displaying a half-life of 3 days, and aspartate displaying a half-life of 30 
days [Table 1].  However, they are not the fastest; notably, the half-life for cysteine is 
only 2 days, the shortest of any amino acid, implying it has a greater propensity for 
racemization than all other physiologic amino acids [Table 1]. 
Interest in serine and aspartate as amino acids whose D-isomers occur 
physiologically in mammalian systems stemmed from screens of mammalian tissues for 
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D and L-isomers of all amino acids (Hashimoto et al., 1992b).  We wondered if in such 
previous studies that systematically looked at the concentration of different D-amino acid 
enantiomers in mammalian systems attempted but failed to demonstrate the presence of 
D-cysteine.  To my surprise, those studies never examined cysteine whose detection 
would have been precluded due to interference with the derivatization procedure 
employed, which relied on thiol containing reagents (Hashimoto et al., 1992b).  The 
method of amino acid derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-
phthaldialdehyde used in such studies (Hashimoto et al., 1992b) to detect D-amino acid 




Chapter 1b.  Results 
 
High-performance liquid chromatography detection of endogenous mammalian D-
cysteine 
Various biological thiols are fluorescently labeled with 4-(aminosulfonyl)-7-fluoro-2,1,3-
benzoxadiazole (ABD-F) (Toyo’oka & Imai, 1984) [Figure 1].  Following labeling, the 
ABD-thiol adducts are chirally separated by direct isocratic elution of an HPLC column 
with a chiral crown ether, CROWNPAK® CR (+) (Chiral Technologies Inc., Wester 
Chester, Pennsylvania) [Figure 2].  Chiral recognition is achieved using an aqueous 
acidic mobile phase; pH 1.0 aqueous perchloric acid.  Under such acidic conditions the 
amino group is protonated to form an ammonium ion which complex with the chiral 
crown ether inside its chiral cavity [Figure 2A].  This enables the chiral crown ether to 
act as a chiral selector for compounds with a primary amino group near their chiral 
center.  The absolute configuration is inferred from the elution order.  In CR (+) the D-
stereoisomer elutes before the L-stereoisomer.  CR (-) has reverse enantioselectivity and 
therefore provides the reverse order of elution relative to the CR (+), i.e., the L-
stereoisomer elutes before the D-stereoisomer [Figure 2B].   
The column is calibrated using known standards of commonly occurring 
biological thiols [Figure 3], the retention times of the standards are noted [Table 2] and 
used to determine the contents of tissue extracts.  This enables us to discriminate and 
quantify D- and L-cysteine after fluorescent labeling of their thiol groups with ABD-F 
[Figure 4].  Utilizing this technique, when we homogenize mouse liver is in Hepes-NaOH 
buffer, pH 7.7, using a tissue grinder, we observe a 1:6 D:L ratio for cysteine [Figure 4D].  
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However, when we extract mouse liver in 1X 2 N HCl for 10 minutes at 99 ºC, we 
observe a 1:1 D:L ratio [Figure 4E].  We confirm that these acid extraction conditions do 
not catalyze the racemization of L-cysteine to D-cysteine.  The fact that the D:L ratio 
increases following acid extraction indicates that D-cysteine might be sequestered in a 
cellular compartment that is not readily lysed by tissue grinder homogenization.  The 
identity of the D-cysteine and L-cysteine peaks are confirmed by their augmentation when 
the samples are spiked with a racemic cysteine mixture [Figure 4F]. 
 
The luciferase bioluminescence assay for the stereo-specific detection of D-cysteine. 
To evaluate the disposition of D-cysteine in tissues we use a simple, sensitive and specific 
assay for D-cysteine.  It is based on the fact that D-cysteine is used in the chemical 
synthesis of D-luciferin, the substrate for firefly luciferase, from 2-cyano-6-
hydroxybenzothiazole (CHBT) [Figure 5] (Niwa et al., 2006; Kajiyama, 2002).  In the 
presence of ATP, firefly luciferase metabolizes D-luciferin generating photons or 
luminescence.  Therefore, if a mixture of CHBT, ATP, and firefly luciferase are added to 
a tissue extract or lysate, luminescence would only be observed if D-cysteine is present, 
reacting with CHBT to form D-luciferin the luminescent substrate for firefly luciferase.  
The assay readily detects 0.1-1.0 µM D-cysteine, and so is suitable for monitoring 
physiologic mammalian tissue levels of D-cysteine [Figure 6].  In the assay, using tris-(2-
carboxyethyl) phosphine (TCEP) as a reducing agent provides better signal than DTT 
[Figure 6].  This assay forms the biochemical basis for the in vivo optical imaging of 
endogenous D-cysteine in transgenic mice overexpressing firefly luciferase. 
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In vivo optical imaging of endogenous D-cysteine in transgenic mice overexpressing 
firefly luciferase. 
FVB-Tg(CAG-luc,-GFP)L2G85Chco/J (Luc+/+) mice harbor the CAG-luc-eGFP L2G85 
transgene which is under the control of the CAG promoter (human cytomegalovirus 
immediate early promoter enhancer with chicken beta-actin/rabbit beta-globin hybrid 
promoter), displaying widespread expression of firefly luciferase (Cao et al., 2004).  
These mice when intravenously injected with CHBT in the dorsal and/or lateral tail vein 
form D-luciferin and bioluminesce in tissues rich in D-cysteine.  Optical imaging of this 
bioluminescence using a Xenogen IVIS 200 imager enables the in vivo optical imaging of 
endogenous D-cysteine.  In vivo optical imaging indicates relatively high levels of D-
cysteine in the eyes and a transverse thoraco-abdominal organ [Figure 7].  Preliminary 
dissections localize the signal from the transverse thoraco-abdominal organ to the 
pancreas, stomach, and duodenum [Figure 8A].  Improved dissection of the pancreas 
from the stomach and duodenum, indicates that D-cysteine is present exclusively in the 
pancreas, and that the signal from the stomach and duodenum arise from residual 
pancreatic tissue surrounding the stomach and duodenum left behind during dissection 
[Figure 8B]. 
 
Impaired vision in serine racemase knockout mice 
Candidate enzymes for the endogenous biosynthesis and degradation of mammalian D-
cysteine are serine racemase and D-amino acid oxidase respectively.  In fact, it would not 
be surprising at all if serine racemase indeed functioned as a cysteine racemase, given the 
close structural similarity between serine and cysteine.  Namely, substituting an oxygen 
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atom in serine for a sulfur atom in cysteine.  Interestingly, serine racemase knockout mice 
(SR-/-) develop an age-related vision impairment, despite there being no statistical 
difference between D-serine levels in the eyeballs of WT and SR-/- mice (Horio et al., 
2011).  The D-serine concentration in the eyeballs is under ~8 µM, relatively low 
compared to hippocampal D-serine levels of ~260 µM (Horio et al., 2011).  On the other 
hand, the eyes have relatively high levels of D-cysteine compared to other organs 
[Figures 7, 8].  All this indicates that the likely culprit for the age-related vision 
impairment in SR-/- mice is D-cysteine deficiency. 
Electroretinogram responses are attenuated in older SR-/- compared to age-
matched WT controls [Figure 9].  Both scotopic a-waves [Figure 9A] and b-waves 
[Figure 9B] are severely attenuated in older SR-/- compared to age-matched WT controls.  
Photopic b-waves are also diminished in older SR-/- compared to age-matched WT 
controls [Figure 9C].  Electroretinogram responses are unaffected in D-amino acid 
oxidase knockout mice (DAAOx-/-) compared to age-matched WT controls [Figure 10].  
Both scotopic b-waves [Figure 10A] and photopic b-waves [Figure 10B] are unaffected 
in DAAOx-/- compared to age-matched WT controls.  The responses of the DAAOx-/- 
mice are slightly better. 
Retinal fundus photography indicates focal disruptions of the retinal pigmented 
epithelium in older SR-/- mice [Figure 11].  In toluidine blue-stained retinal sections, 
overall thinning of the retina is observed in older SR-/- compared to WT [Figure 12].  The 
retinal ganglion cell layer (RGL) is a densely packed mono- and sometimes bi-layer in 
WT versus an interrupted monolayer in SR-/-.  The inner plexiform layer (IPL) is densely 
staining blue in WT versus grey in SR-/-.  The inner nuclear layer (INL), in WT the 
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cytoplasm is homogenously stained with nuclei, in SR-/- the cytoplasm is heterogeneously 
stained, which might indicate vacuolation, with very densely staining swollen and 
pyknotic nuclei.  The outer plexiform layer is densely staining blue in WT versus grey in 
SR-/-.  The outer nuclear layer (ONL) in SR-/-, compared to WT, is less organized.  The 
inner segment (IS) and outer segment (OS) in SR-/-, compared to WT, is less organized.  
The Bruch’s membrane seems thickened in SR-/-, compared to WT.  
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Chapter 1c.  Discussion 
 
Using HPLC we establish the presence of endogenous mammalian D-cysteine [Figure 4].  
The luciferase bioluminescence assay for the stereo-specific detection of D-cysteine 
forms the biochemical basis for the in vivo optical imaging of endogenous D-cysteine in 
transgenic mice overexpressing firefly luciferase.  The assay readily detects 0.1-1.0 µM 
D-cysteine [Figure 6], and so is suitable for monitoring physiologic mammalian tissue 
levels of D-cysteine.  In vivo optical imaging of endogenous D-cysteine in transgenic 
mice overexpressing firefly luciferase indicates relatively high levels of D-cysteine in the 
eyes and a transverse thoraco-abdominal organ [Figure 7], which on dissection is 
identified as the pancreas [Figure 8]. 
Serine racemase is a candidate enzyme for the endogenous biosynthesis of 
mammalian D-cysteine.  In fact, it would not be surprising at all if serine racemase indeed 
functioned as a cysteine racemase, given the close structural similarity between serine 
and cysteine.  Namely, substituting an oxygen atom in serine for a sulfur atom in 
cysteine.  Consistent with the notion that serine racemase functions as a cysteine 
racemase, is that in a [cysteine]:[serine] 2:1 molar ratio, either L-cysteine or D-cysteine 
markedly inhibit (>90%) the in vitro racemization of L-serine by recombinant mouse 
serine racemase (Panizzutti et al., 2001).  Cysteine is the only amino acid whose D-
enantiomer and L-enantiomer both inhibit serine racemization, consistent with cysteine 
also being a substrate of serine racemase and therefore acts as a competitive inhibitor for 
serine racemization.  If both serine and cysteine are equally good serine racemase 
substrates, one would expect that at a [cysteine]:[serine] 2:1 molar ratio, cysteine to 
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inhibit serine racemization by 67%.  Since the observed inhibition is >90% (Panizzutti et 
al., 2001), this suggests that cysteine is a substantially better serine racemase substrate 
than serine itself. 
Interestingly, SR-/- mice develop an age-related vision impairment [Figures 9-11], 
despite there being no statistical difference between D-serine levels in the eyeballs of WT 
and SR-/- mice (Horio et al., 2011).  Eye D-serine levels are ~8 µM, relatively merged 
compared to hippocampal levels of ~260 µM (Horio et al., 2011).  D-cysteine is enriched 
in the eyes [Figures 7, 8], making its deficiency likely responsible for the age-related 
vision impairment observed in SR-/- mice. 
D-amino acid oxidase is a candidate enzyme for the endogenous degradation of 
mammalian D-cysteine.  D-amino acid oxidase using FAD as a cofactor oxidizes D-amino 
acids into the corresponding imino acids, producing hydrogen peroxide and ammonia.  It 
should be noted that it is erroneously reported that D-cysteine is a very poor substrate for 
D-amino acid oxidase (Man & Bada, 1987).  The classic study which measured the 
oxidation rate of various D-amino acids by mammalian D-amino acid oxidase only 
attempted measurements on cystine, not cysteine (Bender & Krebs, 1950).  The reason 
being, the D-amino acid oxidase activity assays are conducted in 0.1 M pyrophosphate 
buffer, pH 8.4; at such alkaline pH, the thiol group of cysteine is readily oxidized, 
particularly given that the air space of the assay flasks are flushed with oxygen.  Since D-
amino acid oxidase is a peroxisomal enzyme, it would be most relevant to assay its 
activity at the physiologic pH of peroxisomes, pH 6.9-7.1 (Jankowski et al., 2001), where 
the thiol group of cysteine is not readily oxidized.  Most D-amino acid oxidase activity 
assays rely on detecting the hydrogen peroxide produced, however this is unsuitable 
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when cysteine is the substrate, because the free thiol on cysteine would react with 
hydrogen peroxide quenching the signal.  A relatively recent study (Bailey et al., 2015) 
assessed in vitro the ability of porcine D-amino acid oxidase to degrade D-cysteine in pH 
7.4 tris reaction buffer by bioluminescently assaying the decrease in D-cysteine levels.  
Their results not only indicate that D-cysteine is a substrate for D-amino acid oxidase, but 
it also suggests that D-cysteine is a substantially better substrate for D-amino acid oxidase 
than D-serine, since an equimolar amount of D-serine did not inhibit D-cysteine 
degradation by D-amino acid oxidase. 
LEA/SENDAI rats, a mutant rat strain naturally lacking D-amino acid oxidase 
(Konno et al., 2009), develop nonobese type 2 diabetes mellitus (Okamura et al., 2013).  




Chapter 1d.  Methods 
 
High-performance liquid chromatography 
Mouse liver is homogenized in 10X Hepes-NaOH buffer, pH 7.7, using a tissue grinder at 
4 ºC for 5 minutes, spun at maximum speed in 4 ºC microfuge for 30 minutes, 
supernatant is used in subsequent steps.  Proteins are precipitated by bringing supernatant 
to 2 N HCl using 10 N HCl.  Alternatively, mouse liver is extracted directly in 1X 2 N 
HCl for 10 minutes at 99 ºC.  In either case, samples are cooled on ice for 30 minutes, 
then spun at maximum speed in 4 ºC microfuge for 30 minutes, supernatant is then used 
in subsequent steps.  To fluorescently label thiols, supernatant is neutralized by adding 
one equivalent NaOH using 10 N NaOH, followed right away with 1 volume equivalent 
of 1.0 mM ABD-F in 0.2 mM sodium borate buffer, pH 8.0, 1 mM EDTA and 0.1 
volume equivalent of 10% tri-n-butyl phosphine in acetonitrile.  The mixture is incubated 
at 50 ºC for 5 minutes in thermomixer with simultaneous mixing at maximum speed, then 
placed on ice, and mixed with 0.01 volume equivalent of 2.5 N HCl.  The fluorescently 
labeled samples are separated using HPLC on a chiral crown ether column, 
CROWNPAK® CR (+) (150 × 4 mm i.d., 5 µM; Chiral Technologies Inc., Wester 
Chester, Pennsylvania).  A mobile phase of pH 1.0 aqueous perchloric acid (1 ml/min 
flow rate) is used for isocratic elution.  The fluorescent ABD adducts are detected using 
fluorescence at an emission wavelength of 510 nm following excitation at 380 nm. 
 
The luciferase bioluminescence assay for the stereo-specific detection of D-cysteine. 
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D-cysteine standards are made in 1X Reaction buffer [500-mM Tricine buffer (89.6 g/l), 
pH 7.8, 100-mM MgSO4 (12 g/l), and 2-mM EDTA (0.832 g/l)], 1 % Triton X-100, 1-
mM TCEP, 0.1 mg/ml 2-cyano-6-hydroxybenzothiazole, and 200-mM potassium 
carbonate.  Wherever possible nitrogen bubbled sterile water is used to prepare the 
solutions.  Samples are incubated at 30 ºC for 10 minutes in thermomixer with 
simultaneous mixing at maximum speed.  Then left to cool on ice for 5 minutes.  20-µl of 
10-N HCl is then added to neutralize the alkalinity of the potassium carbonate.  The 
following are diluted in the final solution before measurements:  10X 50-mM Mg-ATP in 
10-mM Tris pH 7.8, and 500X 2-μl of firefly luciferase 1 mg/ml stock solution in 25-mM 
Tris-acetate (3 g/l Tris base; 0.6 g/l glacial acetic acid), pH 7.8, 0.2-M ammonium sulfate 
(26.4 g/l), 15% (v/v) glycerol and 30% (v/v) ethylene glycol; these can be premixed and 
added together.  Bioluminescence is then measured at 560 nm. 
 
In vivo optical imaging of endogenous D-cysteine in transgenic mice overexpressing 
firefly luciferase. 
FVB-Tg(CAG-luc,-GFP)L2G85Chco/J male mice are anesthetized using isofluorane 
inhalation anesthesia.  The mice are then sterile injected intravenously in the dorsal 
and/or lateral tail vein with CHBT (0.5 µmol in 50 µl of 1:1 DMSO:PBS).  In vivo 





An Espion electroretinogram (ERG) Diagnosys machine (Diagnosys LLC, Littleton, MA, 
USA) is used to record the ERGs.  For scotopic recordings, mice are dark adapted 
overnight, and for photopic recordings, mice are adapted to background white light at an 
intensity of 30 cd/m2 for 10 min.  The mice are anesthetized with an intraperitoneal 
injection of ketamine hydrochloride (100 mg/kg body weight; Fort Dodge Laboratories, 
Fort Dodge, IA) and xylazine (5 mg/kg body weight; Fort Dodge Laboratories, Fort 
Dodge, IA).  The corneas are then anesthetized with topical administration of 0.5% 
proparacaine hydrochloride (Alcon Labs, Forth Worth, TX), pupils are then dilated with 
1% tropicamide (Alcon Labs) and 2.5% phenylephrine (Bausch and Lomb, Tampa, FL).  
Platinum electrodes are then placed on each cornea after application of gonioscopic prism 
solution (Alcon Labs), and a reference electrode is placed subcutaneously in the anterior 
scalp between the eyes, and a ground electrode is inserted into the tail.  Body temperature 
is maintained at 39 °C using a heating pad, light stimuli are provided by a Ganzfeld bowl 
illuminator ensuring equal illumination of the eyes, and responses from each eye are 
simultaneously recorded.  Scotopic ERGs are recorded at 11 intensity levels of white 
light that ranged from −3.00 to 1.40 log cd-s/m2.  Photopic ERGs are recorded at three 
intensity levels of white light ranging from 0.60 to 1.40 log cd-s/m2 with a 30 cd/m2 
background. 
 
Retinal fundus photography 
Mice are anesthetized by intraperitoneal injection of 120 µg/g body weight of ketamine 
hydrochloride (Fort Dodge Laboratories, Fort Dodge, IA).  0.5% tropicamide and 0.5% 
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As previously described (Sarfare et al., 2014) with the exception that transcardial 
perfusion is used to fix the whole mouse prior to enucleation of the eyes. 
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Table 1.  In vitro racemization half-lives of different amino acids (adapted with 
modifications from Man & Bada, 1987). 
 
   Amino acid   Half-life (days)  
           
   Cysteine    2 
Serine     3 
Threonine    20 
Aspartic acid, Methionine  30 
Lysine, Tryptophan   40 
Phenyl alanine, Tyrosine  50 
Alanine    120 




Table 2.  The retention times of various biological thiols derivatized with ABD-F 
separated using a CROWNPAK® CR (+) column containing a chiral crown ether. 
 
   Thiol   Retention time (min)  
           
   D-Cysteine   18.419 
   L-Cysteine   41.743 
   Cysteamine   49.768 
   D-Homocysteine  68.725 
   L-Homocysteine  209.550 
   L-Glutathione   260.672 
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Chapter 1f.  Figures 
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Figure 2.  Structure of the chiral crown ether present in the CROWNPAK® column.   
 
(A) Under acidic conditions the amino group is protonated to form an ammonium ion 
which complex with the chiral crown ether inside the chiral cavity of the crown ether.  
This enables the chiral crown ether to act as a chiral selector for compounds with a 
primary amino group near their chiral center.  (B) The absolute configuration is inferred 
from the elution order.  In CR (+) the D-stereoisomer elutes before the L-stereoisomer.  
CR (-) has reverse enantioselectivity and therefore provides the reverse order of elution 
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Figure 3.  Chromatogram of commonly occurring biological thiols derivatized with 
ABD-F. 
 
(a) 1 nmol ABD-D-cysteine, (b) 1 nmol ABD-L-cysteine, (c) 1 nmol ABD-cysteamine, 
(d) 1 nmol ABD-L-homocysteine, (e) 1 nmol ABD-D-homocysteine, (f) 1 nmol ABD-
glutathione; column, CROWNPAK® CR (+) column 150 × 4 mm i.d., 5 µM;  isocratic 


































































































































Figure 4.  HPLC separation of fluorescent ABD-F adducts of D-cysteine and L-
cysteine using a CROWNPAK® CR (+) column containing a chiral crown ether. 
 
(A) 1 nmol D-cysteine standard.  (B) 1 nmol L-cysteine standard.  (C) 1 nmol racemic 
cysteine mixture standard.  (D) Mouse liver lysate made by homogenizing the liver in 
Hepes-NaOH buffer, pH 7.7, using a tissue grinder.  The D:L ratio of cysteine is 1:6.  (E) 
Mouse live extract made by lysing the liver in 1X 2 N HCl for 10 minutes at 99 ºC.  The 
D:L ratio of cysteine is 1:1.  (F) The sample in E spiked with a racemic cysteine mixture, 









Figure 5.  Chemical synthesis of D-luciferin. 
 
The chiral carbon, marked with an asterisk, of luciferin is from cysteine (adapted with 
modification from Niwa et al., 2006).  This forms the basis of the luciferase 









Figure 6.  Sensitivity of the luciferase bioluminescence assay for the stereo-specific 
detection of D-cysteine. 
 
The assay readily detects 0.1-1.0 µM D-cysteine.  Using TCEP as a reducing agent 









Figure 7.  In vivo optical imaging of endogenous D-cysteine in transgenic mice 
overexpressing firefly luciferase. 
 
(A) Prone position.  (B) Supine position.  In vivo optical imaging indicates relatively high 
levels of D-cysteine in the eyes and a transverse thoraco-abdominal organ.  Luc+/+ male 
mice are anesthetized by isoflurane inhalation anesthesia and sterile injected 
intravenously in the dorsal and/or lateral tail vein with CHBT (0.5 µmol in 50 µl of 1:1 











































Figure 8.  Optical imaging of endogenous D-cysteine in dissected transgenic mice 
overexpressing firefly luciferase, identifies the transverse thoraco-abdominal organ 
rich in D-cysteine as the pancreas. 
 
(A) Preliminary dissections localize the signal from the transverse thoraco-abdominal 
organ to the pancreas, stomach, and duodenum.  (B) Improved dissection of the pancreas 
from the stomach and duodenum, indicates that D-cysteine is present exclusively in the 
pancreas, and that the signal from the stomach and duodenum arise from residual 
























































































Figure 9.  Electroretinogram responses are attenuated in SR-/- compared to age-
matched WT controls. 
 
(A) Scotopic a-waves and (B) b-waves are severely attenuated in SR-/- compared to age-
matched WT controls.  (C) Photopic b-waves are also diminished in SR-/- compared to 




























































Figure 10.  Electroretinogram responses are unaffected in DAAOx-/- compared to 
age-matched WT controls. 
 
(A) Scotopic b-waves and (B) photopic b-waves are unaffected in DAAOx-/- compared to 
age-matched WT controls.  The responses of the DAAOx-/- mice are slightly better.  All 































































Figure 11.  Retinal fundus photography indicates focal disruptions of the retinal 
pigmented epithelium in SR-/- mice. 
 























































































































Figure 12.  Toluidine blue-stained retinal sections of a 21-month old WT mouse and 
an age-matched SR-/- mouse. 
 
Overall thinning of the retina is observed in SR-/- compared to WT.  The retinal ganglion 
cell layer (RGL) is a densely packed mono- and sometimes bi-layer in WT versus an 
interrupted monolayer in SR-/-.  The inner plexiform layer (IPL) is densely staining blue 
in WT versus grey in SR-/-.  The inner nuclear layer (INL), in WT the cytoplasm is 
homogenously stained with nuclei, in SR-/- the cytoplasm is heterogeneously stained, 
which might indicate vacuolation, with very densely staining swollen and pyknotic 
nuclei.  The outer plexiform layer is densely staining blue in WT versus grey in SR-/-.  
The outer nuclear layer (ONL) in SR-/-, compared to WT, is less organized.  The inner 
segment (IS) and outer segment (OS) in SR-/-, compared to WT, is less organized.  The 
Bruch’s membrane seems thickened in SR-/-, compared to WT. 
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Chapter 2.  Conclusion 
 
In conclusion, we establish the presence of endogenous mammalian D-cysteine by HPLC 
utilizing a chiral crown ether column as a chiral selector.  Based on the fact that D-
cysteine is used in the chemical synthesis of D-luciferin, the substrate for firefly 
luciferase, from 2-cyano-6-hydroxybenzothiazole, we develop a method for the in vivo 
optical imaging of endogenous D-cysteine in transgenic mice overexpressing firefly 
luciferase.  Using this method, we find relatively high levels of D-cysteine in the eyes and 
a transverse thoraco-abdominal organ, which on dissection is identified as the pancreas.  
We identify serine racemase and D-amino acid oxidase as candidate enzymes for the 
endogenous biosynthesis and degradation of mammalian D-cysteine respectively.  We 
find that serine racemase knockout mice develop an age-related vision impairment. 
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